CASE STUDIES / Better Investment & Management

Consultancy on Sell of Celltrion Share held by Vaxgen

Celltrion Website
  • M&A

  • Advisory

  • Investment

KEY STATS

  • 154 billion won (KRW)

    130M USD Investment amount

Private equity fund operator (PEF) Centroid Investment and Yellow Sea Management purchased 100% of the old and new shares of Kolon Huiver for 61 billion won(KRW).

BIM acts as Finder for the deal between Centroid Investment and Yellow Sea Management, which is a private equity investment fund (PEF) operator, and Kolon Fire & Marine Insurance.

VaxGen was a biopharmaceutical company based in the San Francisco Bay Area. Founded in 1995 and based in South San Francisco, California, the company was engaged in the development of vaccines that immunize against infectious disease, notably AIDS. On July 28, 2010, VaxGen Inc. was acquired by diaDexus, Inc. in a reverse merger transaction.

Celltrion is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.  Celltrion's founder, Jung Jin Seo, is the second-richest person in South Korea.

XS
SM
MD
LG